These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 24595)

  • 21. [Hemodynamic long-term effects of a beta-receptor blockader (Pindolol) in primary essential hypertension].
    Klein WW; Brandt D; Fluch N; Goebel R; Holzer H; Pöch G
    Adv Clin Pharmacol; 1976; 11():79-85. PubMed ID: 1032573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. alpha-Methyldopa and beta-blockers in hypertension--a comparison of their haemodynamic effects.
    Lund-Johansen P
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():23-34. PubMed ID: 28190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute hemodynamic and neurohumoral effects of pindolol: a beta-adrenoceptor antagonist with high intrinsic sympathomimetic activity in patients with dilated cardiomyopathy.
    Majid PA; Niznick J; Nishizaki S; Morris WM; Sole MJ
    J Cardiovasc Pharmacol; 1987 Sep; 10(3):309-14. PubMed ID: 2444779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reduction of exercise inudced hyperventilation by blocking beta adrenergic receptors].
    Scheen A; Juchmes J; Cession-Fossion A
    C R Seances Soc Biol Fil; 1976; 170(1):220-3. PubMed ID: 9186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
    Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
    Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of the combined effect of alpha-blocking and beta-blocking drugs on tolerance to exertion in patients with acute coronary insufficiency].
    Pavarani A; Volta G; Barbaresi F; Starcich R
    Folia Cardiol; 1969; 28(1):37-41. PubMed ID: 4391632
    [No Abstract]   [Full Text] [Related]  

  • 27. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers.
    Nieminen MS; Rapola J; Pellinen TJ; Toivonen L
    Ann Clin Res; 1988; 20(6):431-5. PubMed ID: 2905879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bufuralol: do beta blockers reduce blood circulation in the kidneys?].
    Truniger B; Bischoff G; Schmidli T
    Schweiz Med Wochenschr; 1983 Sep; 113(37):1331-3. PubMed ID: 6138856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hemodynamic effects of intravenous injection of beta-adrenergic inhibitor (Pindolol) in man].
    Scebat L; Rocha P; Ourbak P; Renais J; Lenègre J
    G Ital Cardiol; 1972; 2(5):626-35. PubMed ID: 4404052
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of ten beta-adrenoceptor blocking agents on spontaneous motility and pentobarbital-induced anaesthesia in mice.
    Barar FS; Madan BR
    Indian J Physiol Pharmacol; 1973; 17(3):235-40. PubMed ID: 4151009
    [No Abstract]   [Full Text] [Related]  

  • 32. Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol.
    Johnston GD; Finch MB; Shanks RG
    Eur J Clin Pharmacol; 1986; 30(6):649-52. PubMed ID: 3533562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vascular reactions of the lower extremities to acute beta blockade at rest and during exertion. A study with beta blockers of different selectivity and activity].
    Rieckert H; Kattwinkel W; Riechelmann H; Kuss A; Sierau R
    Med Welt; 1981 Jun; 32(24):967-71. PubMed ID: 6114381
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacokinetics of two beta blocking drugs: detection of a pharmacogenetic abnormality].
    Balant L; Gorgia A; Tschopp JM; Revillard C; Fabre J
    Schweiz Med Wochenschr; 1976 Oct; 106(41):1403-7. PubMed ID: 12563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bufuralol, a new beta-adrenoceptor blocking agent.
    Fothergill GA; Francis RJ; Hamilton TC; Osbond JM; Parkes MW
    Experientia; 1975 Nov; 31(11):1322-3. PubMed ID: 1287
    [No Abstract]   [Full Text] [Related]  

  • 37. Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.
    Atterhög JH; Dunér H; Pernow B
    Am J Med; 1976 May; 60(6):872-6. PubMed ID: 14501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of beta-adrenergic blocking agents on peripheral vascular resistance.
    Rascher W; Mann JF; Schömig A; Dietz R; Lüth JB
    Klin Wochenschr; 1978; 56 Suppl 1():87-90. PubMed ID: 32434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral haemodynamic effects of beta-adrenoceptor blocking drugs with ISA or relative beta 1-selectivity at rest and during physical exercise.
    Rieckert H; Kattwinkel W; Riechelmann H; Kuss A; Sierau R
    Br J Clin Pharmacol; 1982; 13(Suppl 2):227S-228S. PubMed ID: 6125173
    [No Abstract]   [Full Text] [Related]  

  • 40. Hemodynamic effect of long--term treatment with pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.
    Atterhög JH; Dunér H; Pernow B
    Acta Med Scand; 1977; 202(6):517-21. PubMed ID: 339674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.